Ambit Canada Inc.

Ambit Canada Inc.

Ambit discovers and develops novel drugs aimed at important diseases in the areas of stroke and other CNS disorders, cancer, and inflammation. Our lead drug candidates include neuroprotectants for treatment of stroke and other CNS disorders and kinase inhibitors for treatment of cancer and inflammatory diseases.

Company Details

Company Information

David O'neill
Title: Director Operations
Telephone: (416) 673-8157
Email: Click Here

Products

Kinase Inhibitors

Services